[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"vitamin-k-dependent-coagulation-defect\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:vitamin-k-dependent-coagulation-defect":24},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":22,"conditions":23,"keywords":4,"overallStatus":26,"whyStopped":4,"lastUpdateSubmitDate":27,"lastUpdatePostDateStruct":28,"startDateStruct":31,"completionDateStruct":33,"leadSponsor":35,"locationsCount":5},"100549113","post-marketing-observational-study-on-safety-of-balfaxar-vs-kcentra-for-reversal-of-vitamin-k-antagonist-induced-anticoagulation-in-adults-undergoing-urgent-surgery-or-invasive-procedure-100549113",false,"NCT06429787","Post Marketing Observational Study on Safety of BALFAXAR vs. KCENTRA for Reversal of Vitamin K Antagonist Induced Anticoagulation in Adults Undergoing Urgent Surgery or Invasive Procedure","Post Marketing Observational Study on Safety of BALFAXAR® vs. KCENTRA for Reversal of Vitamin K Antagonist Induced Anticoagulation in Adults Undergoing Urgent Surgery or Invasive Procedure.","Inclusion Criteria:\n\n1. Subjects at least 18 years of age.\n2. Subjects on VKA treatment.\n3. Received 4F-PCC agent, BALFAXAR or Kcentra, for urgent reversal of within 48 hours prior to urgent surgery or invasive procedure.\n\nExclusion Criteria:\n\n1. History of TEE within 90 days before receipt of VKA reversal therapy.\n2. Subjects treated with VKA reversal therapy and not undergoing urgent invasive procedure.","ALL","18 Years",{"count":19,"type":20},3574,"ESTIMATED","OBSERVATIONAL","Post marketing observational study on safety of BALFAXAR vs. KCENTRA for Reversal of Vitamin K Antagonist Induced Anticoagulation in Adults Undergoing Urgent Surgery or Invasive Procedure",[24,25],"Vitamin K-Dependent Coagulation Defect","Significant Bleeding Risk","RECRUITING","2025-06-03",{"date":29,"type":30},"2025-06-04","ACTUAL",{"date":32,"type":30},"2025-02-14",{"date":34,"type":20},"2032-06-30",{"name":36,"class":37},"Octapharma","INDUSTRY"]